Wordt geladen...
Natalizumab in the treatment of multiple sclerosis
Natalizumab is a monoclonal antibody, representing a new class of medication for treating relapsing multiple sclerosis (MS). Conventional treatments include interferons, glatiramer acetate and chemotherapies such as mitoxantrone and cyclophosphamide. These therapies offer only modest clinical benefi...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2724189/ https://ncbi.nlm.nih.gov/pubmed/19707275 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|